These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A case of transient hallucination with ropinirole augmentation antidepressant in a patient with treatment-resistant depression: Is there differential effect of ropinirole dose on developing psychotic symptom? Pae CU; Marks DM; Han C; Patkar AA Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1087-8. PubMed ID: 18384925 [No Abstract] [Full Text] [Related]
4. Tricyclic-induced musical hallucinations and states of relative sensory deprivation. Terao T Biol Psychiatry; 1995 Aug; 38(3):192-3. PubMed ID: 7578664 [No Abstract] [Full Text] [Related]
5. Autoinduction of hypertensive reactions by tranylcypromine? Keck PE; Pope HG; Nierenberg AA J Clin Psychopharmacol; 1989 Feb; 9(1):48-51. PubMed ID: 2486182 [TBL] [Abstract][Full Text] [Related]
6. Symptoms of major depression: acute effect of withdrawing antidepressants. Halle MH; Del Medico VJ; Dilsaver SC Acta Psychiatr Scand; 1991 Mar; 83(3):238-9. PubMed ID: 2031468 [TBL] [Abstract][Full Text] [Related]
7. Autoinduction of hypertensive reactions by tranylcypromine. da Motta T; Cordás TA J Clin Psychopharmacol; 1990 Jun; 10(3):232. PubMed ID: 2376623 [No Abstract] [Full Text] [Related]
8. Tranylcypromine addiction: a case report and review. Briggs NC; Jefferson JW; Koenecke FH J Clin Psychiatry; 1990 Oct; 51(10):426-9. PubMed ID: 2211541 [TBL] [Abstract][Full Text] [Related]
10. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307 [TBL] [Abstract][Full Text] [Related]
12. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression. Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263 [TBL] [Abstract][Full Text] [Related]
13. Amphetamine and tranylcypromine in treatment-resistant depression. Sovner R Biol Psychiatry; 1990 Dec; 28(11):1011-2. PubMed ID: 2275949 [No Abstract] [Full Text] [Related]
15. Treatment with low doses of tranylcypromine resulted in a disappointing remission rate. Nolen WA; van den Broek WW; Birkenhäger TK Am J Psychiatry; 2007 Mar; 164(3):524; author reply 524. PubMed ID: 17329480 [No Abstract] [Full Text] [Related]
16. Addiction to tranylcypromine (Parnate): a case report. Westermeyer J Am J Drug Alcohol Abuse; 1989; 15(3):345-50. PubMed ID: 2763988 [TBL] [Abstract][Full Text] [Related]
17. Thrombocytopenia and delirium associated with tranylcypromine overdose. Chatterjee A; Tosyali MC J Clin Psychopharmacol; 1995 Apr; 15(2):143-4. PubMed ID: 7782490 [No Abstract] [Full Text] [Related]
18. Somatosensory evoked potentials as indicators of altered cerebral excitability during psychotropic drug treatment. Förstl H; Zagorski A; Pohlmann-Eden B Biol Psychiatry; 1991 Feb; 29(4):397-402. PubMed ID: 1903661 [TBL] [Abstract][Full Text] [Related]